PubRank

Stefan Ambs

Author PubWeight™ 109.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006 40.09
2 MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009 6.13
3 Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res 2008 3.39
4 The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 2008 2.72
5 Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010 2.65
6 Retracted FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest 2011 2.44
7 A stromal gene signature associated with inflammatory breast cancer. Int J Cancer 2008 2.18
8 MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest 2013 1.89
9 Association of breast cancer outcome with status of p53 and MDM2 SNP309. J Natl Cancer Inst 2006 1.88
10 Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008 1.86
11 A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet 2013 1.82
12 Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One 2009 1.72
13 A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression. PLoS Genet 2011 1.60
14 Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet 2007 1.55
15 Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest 2010 1.52
16 MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2011 1.39
17 Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J Cancer 2007 1.38
18 Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis 2012 1.38
19 Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med 2009 1.31
20 Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst 2012 1.30
21 Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis. Int J Cancer 2006 1.23
22 Superoxide fluxes limit nitric oxide-induced signaling. J Biol Chem 2006 1.22
23 Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. Breast Cancer Res Treat 2011 1.19
24 Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. PLoS One 2012 1.15
25 Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 2008 1.14
26 Biological determinants of health disparities in prostate cancer. Curr Opin Oncol 2013 1.12
27 A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 2012 1.11
28 Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis 2011 1.10
29 Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity. Clin Cancer Res 2012 1.09
30 NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Mol Cancer 2010 1.06
31 Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 2007 1.05
32 Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. Breast Cancer Res 2012 1.02
33 S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer. Mol Cancer Res 2012 1.01
34 Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci U S A 2014 1.01
35 Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013 1.01
36 COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer. BMC Cancer 2010 0.99
37 Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer 2013 0.99
38 Association of MTHFR gene polymorphisms with breast cancer survival. BMC Cancer 2006 0.98
39 Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis 2013 0.95
40 Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer. Trends Pharmacol Sci 2011 0.94
41 A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide. Clin Cancer Res 2009 0.94
42 MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. Int J Cancer 2012 0.93
43 Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. PLoS One 2012 0.91
44 The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women. Carcinogenesis 2006 0.90
45 A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Res 2014 0.90
46 Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer. Genes Cancer 2011 0.89
47 Differential effects of reactive nitrogen species on DNA base excision repair initiated by the alkyladenine DNA glycosylase. Carcinogenesis 2009 0.87
48 Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Res 2012 0.83
49 Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Res Treat 2011 0.81
50 Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother 2013 0.81
51 Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiol Biomarkers Prev 2012 0.80
52 Household income is associated with the p53 mutation frequency in human breast tumors. PLoS One 2013 0.79
53 S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer. For Immunopathol Dis Therap 2012 0.76
54 Analysis of stromal gene expression for the identification of prognostic and predictive molecular markers in cancer therapy. Int J Cancer 2012 0.75